Virtually eliminating the spread of HIV? Ten years ago ,the idea that we could end new cases of HIV spread through sexual contact would have been seen as a pipe dream. But, thanks to pharmaceutical advances, a new drug in the United States has the potential to make those dreams a reality. Pre-exposure prophylaxis, more commonly known as PrEP, is a pill that, if taken daily, can reduce the risk of contracting HIV from sexual contact by up to 99%. In 2014, the Centers for Disease Control and Prevention reported that 68% of new HIV cases can be attributed to men who have sex with other men. PrEP is meant only for people who are currently HIV negative and is targeted towards men who have sex with men as well as those that that have sex with men engaged in same sex activity. PrEP was among methods listed when the United States Department of Health and Human Services released a plan in 2019 with the goal of slowing the spread of HIV. While the drug is relatively new to the market, awareness